Pascal Bamford
Chief Clinical Officer at Akoya Biosciences, Inc. (AKYA) since August 2024
Pascal Bamford has filed 6 insider reports with the SEC since September 2024, as chief Clinical Officer at Akoya Biosciences, Inc. (AKYA). The latest filing, on July 11, 2025, reports other acquisition or disposition at Akoya Biosciences, Inc. (AKYA).
- Filings
- 6
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Pascal Bamford is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Clinical Officersince August 2024 | 0 | Jul 11, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jul 8, 2025AKYAChief Clinical Officer Bamford Pascal disposed of 205,738 shares, closing all direct ownership in the companyForm 4Other acquisition or disposition
- Jun 1, 2025AKYAChief Clinical Officer Bamford Pascal covered exercise/tax liability with 670 shares, decreasing direct ownership by 0.32% to 205,738 unitsForm 4Shares withheld for taxes or exercise price
- Mar 1, 2025AKYAChief Clinical Officer Bamford Pascal covered exercise/tax liability with 3,850 shares, decreasing direct ownership by 2% to 206,408 unitsForm 4Shares withheld for taxes or exercise price
- Nov 19, 2024AKYAChief Clinical Officer Bamford Pascal was granted 87,500 shares, increasing direct ownership by 71% to 210,258 unitsForm 4Grant or award
- Aug 29, 2024AKYAChief Clinical Officer Bamford Pascal was granted 40,000 shares, increasing direct ownership by 48% to 122,758 unitsForm 4Grant or award
- Aug 29, 2024AKYANew insider Bamford Pascal claimed ownership of 82,758 sharesForm 3New insider
Compare Pascal Bamford with
- Pascal Bamford vs Scott Mendel1 shared
- Pascal Bamford vs Niro Ph.D Ramachandran1 shared
- Pascal Bamford vs Brian McKelligon1 shared
- Pascal Bamford vs Jennifer Kamocsay1 shared
- Pascal Bamford vs John Frederick Ek1 shared
- Pascal Bamford vs Matthew Winkler1 shared
Other insiders at the same companies
- Scott MendelAKYA
- Niro Ph.D RamachandranAKYA
- Brian McKelligonAKYA
- Jennifer KamocsayAKYA
- John Frederick EkAKYA
- Matthew WinklerAKYA
- Robert G SheplerAKYA
- Thomas P SchnettlerAKYA
- Thomas A. RaffinAKYA
- Goldman Myla LaiAKYA
Questions about Pascal Bamford
- What is Pascal Bamford's role at Akoya Biosciences, Inc.?
- Pascal Bamford reports to the SEC as chief Clinical Officer at Akoya Biosciences, Inc. (AKYA), according to the latest filing on July 11, 2025.
- Has Pascal Bamford bought or sold stock recently?
- No open-market purchases or sales by Pascal Bamford are on file. The filings report other acquisition or disposition, shares withheld for taxes or exercise price and grant or award.
- How do I get alerts when Pascal Bamford files?
- Follow Pascal Bamford on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Pascal Bamford (SEC CIK 0002035474). Totals count each trade once, skipping amendments whose original is on file, from Sep 4, 2024 on. View on SEC EDGAR · Get this as JSON